Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
35.0%
% of XPH's 40 holdings also in PJP
63.6%
% of PJP's 22 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.1% | 6.0% | 5.1% |
|
PFIZER INC | 4.8% | 5.7% | 4.8% |
|
ELI LILLY & CO | 4.7% | 5.8% | 4.7% |
|
JOHNSON & JOHNSON | 4.6% | 5.7% | 4.6% |
 |
PERRIGO CO | 5.0% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PJP
|
INTRA-CELLULAR THERAPIES INC | 5.3% |
|
CATALENT INC | 4.9% |
|
ORGANON & CO. | 4.8% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
AXSOME THERAPEUTICS, INC. | 4.6% |
|
VIATRIS, INC. | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
|
ZOETIS INC | 4.0% |
|
ELANCO ANIMAL HEALTH, INC. | 3.9% |
|
ARVINAS, INC. | 2.8% |
XPH Underweight Relative to PJP
|
GERON CORP | -7.1% |
|
AMGEN INC | -5.7% |
|
ABBVIE INC | -5.7% |
|
REGENERON PHARMACEUTICALS | -5.7% |
|
ABBOTT LABORATORIES | -5.6% |
|
UNITED THERAPEUTICS CORP | -4.2% |
|
BIOSANTE PHARMACEUTICALS INC | -3.6% |
|
GILEAD SCIENCES INC | -3.5% |
|
BIOGEN IDEC INC | -3.3% |
|
SUPERNUS PHARMACEUTICALS INC | -3.0% |